📅 PUBMED DAILY TRIAGE — 2026-04-30
Window: 2026-04-29T09:00:00Z → 2026-04-30T09:00:00Z (CRDT) Topics scanned: 10 | Articles reviewed: ~100 candidates | Candidates evaluated: 16 kept High priority: 2 | Standard: 10 | Low/archive: 4 | Unsolicited finds: 1 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
💊 Cardiovascular-Metabolic: GLP-1, SGLT2, Cardiometabolic Risk
TR-2026-04-30-001 / PMID 42056284 · APSH+DASG Consensus on Hypertension Management in Diabetes (Asia-Pacific) · 8/10 · 🟢 NEAR_TERM_IMPLEMENTABLE
First joint 15-country Asia-Pacific hypertension+diabetes guideline using GRADE framework; formally endorses SGLT2i and GLP-1 RA for cardio-renal protection with BP target <130/80 mmHg — immediately applicable to the world's highest-burden cardiometabolic region.
TR-2026-04-30-002 / PMID 42056522 · GLP-1R-GIPR-PPARα/γ/δ quintuple agonist corrects obesity/diabetes in mice (Nature) · 5/10 [FLAG: NOVEL_TREATMENT → HIGH] · 🟠 NOVEL_TREATMENT
First-in-class unimolecular quintuple agonist (GLP-1-GIP-lanifibranor) outperforms semaglutide and dual GLP-1/GIP co-agonism in obese mice; published in Nature (Helmholtz Munich); preclinical only — triage score capped at 5 per non-human rule, but NOVEL_TREATMENT flag triggers HIGH pipeline priority.
🟢⚪ STANDARD (5-7) — Top by Topic
🩸 Hematologic Malignancies
| Record | Title | Score | Category |
|---|---|---|---|
| TR-2026-04-30-003 / PMID 42056531 | Multi-omics of pediatric AML-M0: RUNX1-driven stemness (Leukemia) | 7/10 | Genomics/Precision Med |
| TR-2026-04-30-004 / PMID 42056569 | CXCR4-targeted PET/CT vs MRI/FDG-PET in primary CNS lymphoma, n=29 | 7/10 | Diagnostics |
| TR-2026-04-30-009 / PMID 42056616 | CMV infection in hematologic malignancy+sepsis: WBC as early indicator, n=119 | 5/10 | Diagnostics |
💡 Early Cancer Detection (Liquid Biopsy / ctDNA)
| Record | Title | Score | Category |
|---|---|---|---|
| TR-2026-04-30-006 / PMID 42055889 | RET fusions as EGFR-TKI resistance; ddPCR liquid biopsy predicts progression (n=9, German nNGM) | 6/10 | Diagnostics / Genomics |
🤖 AI/ML in Clinical Diagnostics
| Record | Title | Score | Category |
|---|---|---|---|
| TR-2026-04-30-007 / PMID 42056720 | ML for CI-AKI prediction: AUC=0.807 outperforms Mehran score, n=3,437 | 6/10 | Diagnostics |
| TR-2026-04-30-012 / PMID 42056808 | Systematic review ML/DL EEG depression detection (42 studies; QUADAS-2 bias assessment) | 6/10 | Diagnostics / Mental Health |
🎯 Novel Therapeutics (Immunotherapy / Targeted)
| Record | Title | Score | Category |
|---|---|---|---|
| TR-2026-04-30-008 / PMID 42056724 | HIF inhibitors synergize with ICIs: review of TME remodeling strategies (Int J Cancer) | 6/10 | Treatment Innovation |
👴 Aging / Longevity / Population Health
| Record | Title | Score | Category |
|---|---|---|---|
| TR-2026-04-30-005 / PMID 42045982 | N-acetylcysteine RCT in MCI + exercise cardiac rehab (Sunnybrook, CIHR-funded) | 7/10 | Prevention |
| TR-2026-04-30-011 / PMID 42045968 | BUN-albumin ratio predicts 30-day mortality in geriatric hip fracture, n=514 (AUC=0.82) | 6/10 | Diagnostics |
🧬 Rare Diseases
| Record | Title | Score | Category |
|---|---|---|---|
| TR-2026-04-30-010 / PMID 42056755 | Placebo effect in rare disease trials: own-control designs are viable (Janet Woodcock, FDA) | 6/10 | Other / Drug Development |
💡 UNSOLICITED FINDS
TR-2026-04-30-013 / PMID 42045987 — MSC exosomes in injectable hydrogels for diabetic foot ulcers (Stem Cell Res Ther, review). Score 4/10. Notable regenerative medicine approach combining exosome delivery with biomimetic hydrogels; addresses DFU — a significant diabetes complication with high amputation risk. Preclinical/review stage; not actionable now but worth monitoring.
📊 TODAY'S BREAKDOWN
By research category:
- Diagnostics: 7
- Treatment Innovation / Drug Development: 5
- Genomics/Precision Medicine: 2
- Prevention: 2
- Other (trial methodology): 1
- Out-of-watchlist: 1
By evidence maturity:
- Exploratory: 9
- Validated: 5
- Potentially Practice-Changing: 1 (TR-2026-04-30-001)
- (not assessed/low): 1
By watchlist topic (reviewed / kept / highest score):
| Topic | Reviewed | Kept | Highest Score |
|---|---|---|---|
| Hematologic malignancies | 10 | 3 | 7 |
| CBC diagnostics + ML | 10 | 0 | 0 (SPARSE — 7th window) |
| Early cancer detection | 10 | 2 | 6 |
| AI/ML diagnostics | 10 | 2 | 6 |
| Precision oncology/genomics | 10 | 2 | 7 (shared w/ hematology) |
| Novel therapeutics | 10 | 2 | 5 (Nature flag→HIGH) |
| Cardiometabolic GLP-1/SGLT2 | 10 | 2 | 8 ✅ |
| Aging / longevity | 10 | 2 | 7 |
| Rare diseases | 10 | 1 | 6 |
| Sentinel scan | 10 | 0 | 0 |
By source type: peer_reviewed: 16 | preprint: 0
Topics with zero 8+ articles today:
- Hematologic malignancies, CBC/ML hematology, Early cancer detection, AI/ML diagnostics, Precision oncology, Novel therapeutics (flagged HIGH via NOVEL_TREATMENT), Aging/longevity, Rare diseases, Sentinel
🔧 RUN NOTES
- Window expansion: NOT triggered (≥5 relevant records found in 24h window)
- Deferred PMIDs processed: 10 from previous run. 6 excluded as out-of-watchlist (orthopedic analgesia, anger management, wound care RCT protocol). 4 included (42045987, 42045982, 42045970, 42045968).
- New deferred PMIDs for next run: 9 PMIDs (42056650, 42056648, 42055316, 42054842, 42056639, 42056619, 42055801, 42055601, 42054834) — from topics with cap truncation
- CBC/ML Hematology: 7th consecutive sparse CRDT window. No dedicated CBC+ML papers found. PMID 42056616 (WBC predictor in hematologic malignancy) was the only overlapping signal.
- Aging search quality: Broad MeSH expansion returned water research and materials science papers matching "aging"; these were excluded. Consider narrowing query to include only [MeSH Terms] for aging in future runs.
- Preclinical cap applied: PMID 42056522 (Nature) scored 5/10 (non-human cap) but NOVEL_TREATMENT flag elevates to HIGH. PMID 42056832 (veterinary equine) scored 2/10.
- Rolling 7-day pattern (from state): CBC/ML topic has produced zero high-priority articles across all recent runs. Consider query refinement or watchlist expansion for this area.
- Abstract-only assessment: All 16 articles assessed from abstract only; no PMC full text accessed. Classification confidence noted accordingly.
- Sentinel scan: 822 raw results across 24h window; top 10 reviewed; all captured items overlapped with existing watchlist topics; PMID 42045987 (MSC/DFU review) was the only new unsolicited find.